Cancer Tumour Testing – LINK Medical

Unique treatment tailored to your cancer

We offer comprehensive genomic testing (DNA, RNA, Proteins) through our exclusive partner, Tempus. Our unique test options can be performed to identify specific alterations that may drive the behaviour of your cancer. This can help your doctor develop a personalised treatment plan specifically for you.

"Having Tempus in my fight for Cancer... it's incredible"

What is Molecular Profiling?

Tempus Labs performs thorough molecular testing on DNA, RNA and proteins, utilising the most technically advanced systems, including the world’s most advanced AI-based algorithms, to identify the biomarkers relevant for optimised treatment decisions in a patient’s tumour, and to compare the biomarkers with data from clinical studies around the world. This is a powerful asset to aid clinical decisions regarding individual cancer therapies. Tempus Lab’s comprehensive molecular profiling enables clinicians to:

Identify therapies with potential benefit
Identify therapies which may not have been considered before
Determine drugs with potential lack of benefit (avoiding unnecessary toxicities and costs)
Match patients to appropriate clinical trials

Interested in taking a Tempus Lab test?

We would be happy to share more detailed information and clinical evidence on Tempus products and services through LINK Medical.

How It Works

Contact LINK Medical

Email Now

LINK Medical will send requisition form to treating physician.

LINK Medical will obtain consent form and terms of service from patient.

LINK Medical will arrange packaging and collection of the patient's specimen sample.

Tempus completes multi-genomic profiling.

Report is sent directly to treating physician. Report sent to patient upon request.

1:1 telephone meeting is offered to the treating physician directly.

What are biomarkers?

A biomarker is any physical characteristic of the human body that can be measured. Your blood pressure is a biomarker. A haemoglobin level is a biomarker. Some biomarkers can be linked to a particular diagnosis, to disease outcomes, or to response to medication or other therapy. In oncology, important biomarkers that can be measured include the DNA, RNA, and protein within a tumour. These biomarkers can be used to make a diagnosis, to predict cancer aggressiveness, or to predict that a particular therapy will be effective.

DNA

DNA (deoxyribonucleic acid) is a molecule inside the cell that carries genetic information and passes it on from one generation to the next. DNA biomarkers can be evaluated for aberrations such as gene mutations or copy number alterations (e.g. gene amplification) that can cause a cancer cell to proliferate.

Who can benefit from a Tempus Lab test?

Patients with metastatic cancer looking for a personalised approach to their treatment and care. Tempus have the following products:

Tempus xT

Tissue test that sequences 648 DNA genes, whole transcriptome RNA, immunotherapy biomarkers, as well as AI-based algorithm tests for additional information.

Tempus xF

Blood test that sequences 105 cfDNA genes, as well as MSI status.

Tempus Concurrent

Tissue and Blood test that enhances overall mutation alteration detection for an even more comprehensive report to better understand the cancer’s biology and treatment options.

Tempus Longitudinal

Blood test that is done each time the cancer progresses to identify most relevant mutation alterations which can support ongoing treatment plans.

Would you like to find out more about TEMPUS cancer tests?

Do you have metastatic cancer and looking for a personalised approach to your treatment plan? Contact us today to find out how we can help you.